Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results

Eriene A. Youssef,Elizabeth Berry-Kravis,Christian Czech,Randi J. Hagerman,David Hessl,Chin Y Wong,Michael Rabbia,Dennis Deptula,Amy John,Russell Kinch,Philip Drewitt,Lothar Lindemann,Moritz Marcinowski,Rachel Langland,Carsten Horn,Paulo Fontoura,Luca Santarelli,Jorge A. Quiroz

Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results

2018

Eriene A. Youssef
Elizabeth Berry-Kravis
Christian Czech
Randi J. Hagerman
David Hessl
Chin Y Wong
Michael Rabbia
Dennis Deptula
Amy John
Russell Kinch
Philip Drewitt
Lothar Lindemann
Moritz Marcinowski
Rachel Langland
Carsten Horn
Paulo Fontoura
Luca Santarelli
Jorge A. Quiroz

Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results

Keywords:

Fragile X syndrome
Psychology
Placebo-controlled study
Physical therapy
Psychiatry
Phases of clinical research
Anesthesia
Clinical trial
FMR1
Internal medicine
Adverse effect
Placebo
Psychosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations